# SEO-Friendly Podcast Description
**Title Option:** Wegovy's New Chapter: Tablets, Trials, and the Global Weight-Loss Drug Battle
**Description:**
Wegovy is evolving fast—and this episode breaks down everything you need to know as of October 2026. From the quiet launch of the Wegovy tablet in Germany to Citi's bold $13 billion sales forecast, we're unpacking the latest twists in the obesity drug landscape.
This episode covers:
✅ **The Wegovy tablet rollout in Germany** — why demand has been muted despite semaglutide's star power
✅ **Wall Street's mixed signals** — Citi and Deutsche Bank raise near-term forecasts while cutting long-term price targets for Novo Nordisk
✅ **New liver health research** — STEP UP study findings suggest semaglutide may reduce liver fat beyond just weight loss
✅ **Real-world data from OCTANE** — how patients fare switching from injectable GLP-1s to oral Wegovy
✅ **South Korea's GLP-1 boom** — Hanmi Pharmaceutical's new domestic rival, plus a crackdown on nearly 1,000 illegal online obesity drug listings
✅ **WHO's new pediatric obesity guidance** — why lifestyle intervention comes first for kids and teens
✅ **Pricing pressure** — Novo Nordisk cuts Wegovy prices 20% in Sweden to improve treatment adherence
✅ **The end of compounded semaglutide** — what the Hims & Hers controversy means for patients seeking cheaper alternatives
Whether you're a patient, healthcare provider, investor, or just someone following the GLP-1 revolution, this episode delivers the nuanced, fact-checked context behind the headlines—without the hype.
**Keywords:** Wegovy, semaglutide, Novo Nordisk, GLP-1 drugs, obesity medication, weight loss drugs, Wegovy tablet, pharmaceutical news, diabetes medication, liver health, WHO guidelines, drug pricing, Mounjaro competitor, weight loss pills 2026
**Perfect for listeners interested in:** pharma industry news, obesity treatment options, healthcare policy, GLP-1 medication updates, and evidence-based medical reporting.
---
Some great Deals https://amzn.to/49SJ3Qs
For more check out http://www.quietplease.ai
